Cargando…
Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century
INTRODUCTION: The advent of tyrosine kinase inhibitors has produced 5-year survival of 90 + % for chronic myelocytic leukemia (CML) patients in clinical trials. However, population level survival has been lower, especially in older patients. Here, we examine survival of patients with CML in Germany...
Autores principales: | Pulte, Dianne, Barnes, Benjamin, Jansen, Lina, Eisemann, Nora, Emrich, Katharina, Gondos, Adam, Hentschel, Stefan, Holleczek, Bernd, Kraywinkel, Klaus, Brenner, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848850/ https://www.ncbi.nlm.nih.gov/pubmed/24499592 http://dx.doi.org/10.1186/1756-8722-6-70 |
Ejemplares similares
-
Survival from colorectal cancer in Germany in the early 21st century
por: Majek, O, et al.
Publicado: (2012) -
Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage
por: Chen, Tianhui, et al.
Publicado: (2012) -
Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States
por: Pulte, Dianne, et al.
Publicado: (2014) -
Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century
por: Pulte, Dianne, et al.
Publicado: (2020) -
Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century
por: Pulte, Dianne, et al.
Publicado: (2016)